Authors:
SPRINGER CJ
SPOONER RA
FRIEDLOS F
MARTIN J
STRIBBLING S
DAVIES L
NICULESCUDUVAZ D
NICULESCUDUVAZ I
MAYCROFT K
LIGHT Y
MARAIS R
Citation: Cj. Springer et al., NEW ENZYME PRODRUG COMBINATIONS FOR USE IN GENE-DIRECTED ENZYME PRODRUG THERAPY (GDEPT)/, Cancer gene therapy, 4(6), 1997, pp. 106-106
Citation: I. Niculescuduvaz et Cj. Springer, ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) - A REVIEW, Advanced drug delivery reviews, 26(2-3), 1997, pp. 151-172
Citation: Cj. Springer et I. Niculescuduvaz, GENE-DIRECTED ENZYME PRODRUG THERAPY (GDEPT) - CHOICE OF PRODRUGS, Advanced drug delivery reviews, 22(3), 1996, pp. 351-364
Citation: Cj. Springer et I. Niculescuduvaz, ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT) WITH MUSTARD PRODRUGS, Anti-cancer drug design, 10(5), 1995, pp. 361-372
Authors:
SPRINGER CJ
DOWELL R
BURKE PJ
HADLEY E
DAVIES DH
BLAKEY DC
MELTON RG
NICULESCUDUVAZ I
Citation: Cj. Springer et al., OPTIMIZATION OF ALKYLATING AGENT PRODRUGS DERIVED FROM PHENOL AND ANILINE MUSTARDS - A NEW CLINICAL CANDIDATE PRODRUG (ZD2767) FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT), Journal of medicinal chemistry, 38(26), 1995, pp. 5051-5065
Citation: I. Niculescuduvaz et Cj. Springer, 1-ADAMANTYLOXYCARBONYL - A NOVEL PROTECTING GROUP FOR PHENOLS CARRYING STRONGLY ELECTRON-WITHDRAWING SUBSTITUENTS, Journal of chemical research. Synopses, (6), 1994, pp. 242-243
Citation: Cj. Springer et al., NOVEL PRODRUGS OF ALKYLATING-AGENTS DERIVED FROM 2-FLUOROBENZOIC AND 3-FLUOROBENZOIC ACIDS FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY, Journal of medicinal chemistry, 37(15), 1994, pp. 2361-2370